Dewey DC, et al. APDM gait and balance measures fail to predict symptom progression rate in Parkinson’s disease. Frontiers in Neurology. 2022;13:1041014. DOI 10.3389/fneur.2022.1041014
This note indexes a cited or audit-added source. It may be an original study, review, guideline, form or methods reference. Treat the specific design and the evidence below as authoritative; a source note is not automatically a primary study.
DOI: 10.3389/fneur.2022.1041014
Bibliographic record from the original reports
Access labels embedded in these original reference strings are historical. Current access and exact checked components are stated separately below.
Dewey DC, et al. APDM gait and balance measures fail to predict symptom progression rate in Parkinson’s disease. Frontiers in Neurology. 2022;13:1041014. DOI 10.3389/fneur.2022.1041014
Dewey DC, Chitnis S, McCreary MC, et al. APDM gait and balance measures fail to predict symptom progression rate in Parkinson's Disease. Frontiers in Neurology. 2022. DOI 10.3389/fneur.2022.1041014
Dewey DC, Chitnis S, McCreary MC, et al. APDM gait and balance measures fail to predict symptom progression rate in Parkinson’s disease. Frontiers in Neurology. 2022;13:1041014. Original article
Conditions: COND-PD Parkinson’s disease
Scoped audit evidence
These are source- and component-level audit summaries as of 3 October 2026. Access and comparison scope can differ by report; none certifies every result or the underlying raw data.
Parkinson’s disease — gait
- access status: primary_body_retrieved
Latest listed audit check, current for its stated components. Later recovery/refinement here supersedes earlier access limitations only where explicitly stated; it does not resolve unrelated source contradictions.
Balance P204/P210/P252–254:230/222/164/177followups;ON3x30smedian,firmarmscrossedfeet26cm;iSway2at24monthsMoCA48.12%,MDS59.40%,Schwab59.79%. All matchoriginalTable3;gamma-derived metric notAUC/classificationaccuracy. Source locator: s3protocol;s4statistics;s5Tables1–3 Limit: Internal repeated tenfoldvalidationonly.
Earlier audit check 1 (historical evidence record). Its access limitations are superseded wherever the latest check above explicitly closes them. Retained for the distinct components and provenance, not as a current access statement.
GaitP160,P172,P187-189:ON protocol baseline iTUG/iSway;6/12/18/24moN230/222/164/177;24m iTUG-UPDRS58.21%SD8.87;repeated10fold1000replicateCV;Gamma(C-D)/(C+D)concordance not ordinaryclassificationaccuracy;PDQ39mobility/SEnotglobalQoL;poorlateoutofsampleprediction. Balanceprotocol30secfirm26cmfeetarmscrossed3trialsmedian;V1/V2changes. Source locator: s3Experimentalprotocol;s4AnalyticPlan;s5ResultsTables1-3 Limit: SupplementTable2 featuredefinitions not checked. Mainpaper does not fully detailmissingnesshandling.
Limitations: Only scoped comparisons, not whole-paper certification.
Parkinson’s disease — balance
- access status: primary_body_retrieved
Latest listed audit check, current for its stated components. Later recovery/refinement here supersedes earlier access limitations only where explicitly stated; it does not resolve unrelated source contradictions.
Balance P204/P210/P252–254:230/222/164/177followups;ON3x30smedian,firmarmscrossedfeet26cm;iSway2at24monthsMoCA48.12%,MDS59.40%,Schwab59.79%. All matchoriginalTable3;gamma-derived metric notAUC/classificationaccuracy. Source locator: s3protocol;s4statistics;s5Tables1–3 Limit: Internal repeated tenfoldvalidationonly.
Earlier audit check 1 (historical evidence record). Its access limitations are superseded wherever the latest check above explicitly closes them. Retained for the distinct components and provenance, not as a current access statement.
GaitP160,P172,P187-189:ON protocol baseline iTUG/iSway;6/12/18/24moN230/222/164/177;24m iTUG-UPDRS58.21%SD8.87;repeated10fold1000replicateCV;Gamma(C-D)/(C+D)concordance not ordinaryclassificationaccuracy;PDQ39mobility/SEnotglobalQoL;poorlateoutofsampleprediction. Balanceprotocol30secfirm26cmfeetarmscrossed3trialsmedian;V1/V2changes. Source locator: s3Experimentalprotocol;s4AnalyticPlan;s5ResultsTables1-3 Limit: SupplementTable2 featuredefinitions not checked. Mainpaper does not fully detailmissingnesshandling.
Limitations: Only scoped comparisons, not whole-paper certification.
Parkinson’s disease — balance1
- access status: primary_body_retrieved
Latest listed audit check, current for its stated components. Later recovery/refinement here supersedes earlier access limitations only where explicitly stated; it does not resolve unrelated source contradictions.
Balance P204/P210/P252–254:230/222/164/177followups;ON3x30smedian,firmarmscrossedfeet26cm;iSway2at24monthsMoCA48.12%,MDS59.40%,Schwab59.79%. All matchoriginalTable3;gamma-derived metric notAUC/classificationaccuracy. Source locator: s3protocol;s4statistics;s5Tables1–3 Limit: Internal repeated tenfoldvalidationonly.
Earlier audit check 1 (historical evidence record). Its access limitations are superseded wherever the latest check above explicitly closes them. Retained for the distinct components and provenance, not as a current access statement.
GaitP160,P172,P187-189:ON protocol baseline iTUG/iSway;6/12/18/24moN230/222/164/177;24m iTUG-UPDRS58.21%SD8.87;repeated10fold1000replicateCV;Gamma(C-D)/(C+D)concordance not ordinaryclassificationaccuracy;PDQ39mobility/SEnotglobalQoL;poorlateoutofsampleprediction. Balanceprotocol30secfirm26cmfeetarmscrossed3trialsmedian;V1/V2changes. Source locator: s3Experimentalprotocol;s4AnalyticPlan;s5ResultsTables1-3 Limit: SupplementTable2 featuredefinitions not checked. Mainpaper does not fully detailmissingnesshandling.
Limitations: Only scoped comparisons, not whole-paper certification.
Parkinson’s disease — transfer
- access status: primary_body
Follow-up n=230/222/164/177 at six/12/18/24 months. Baseline APDM instrumented-TUG battery includes rising/descent; ridge models with repeated held-out evaluation perform poorly for longer-term outcomes. Modest six-month prediction occurs where clinical change is small.
Limitations: Only the enumerated transfer-relevant components were adjudicated. Source availability does not imply every statement, supplement, figure or raw datum was checked.
Reports citing this source
- Gait analysis and prognosis in Parkinson’s disease · reference 7 · original reference
- Standing balance assessment and prognosis in Parkinson’s disease · reference 15 · original reference
- Standing balance assessment and prognosis in Parkinson’s disease · reference 15 · original reference
- Sit to stand and functional transfer assessment and prognosis in Parkinson’s disease · reference 57 · original reference
Update record
- 2026-10-03: Created from the supplied reports and final scoped audit. New evidence should be appended with source version, access date, exact locator and affected report links.
Updating the wiki · Evidence and status guide